Search
for
Sort by
Research 271–300 of 1000+
- Immune cell regulation of the hair cycle
- Alopecia Areata: A Review of the Role of Oxidative Stress, Possible Biomarkers, and Potential Novel Therapeutic Approaches
- Topical SCD-153, a 4-methyl itaconate prodrug, for the treatment of alopecia areata
- The immunopathogenesis of Alopecia Areata
- Impacto del desequilibrio del microbioma del cuero cabelludo en la severidad de la alopecia areata, marcadores inflamatorios y cambios post-tratamiento
- Beyond the follicle
- Hair restoration and regenerative medicine: Scope, science, and the road ahead
- BH17 Bridging the gap: identifying dual-targeting therapies for patients with alopecia areata and coexisting immune-mediated inflammatory diseases
- Treatment of frontal fibrosing alopecia: literature review 2020-2025
- Registrars and Fellows Update Session 2
- 63-Year-Old Female with Diffuse Thinning of the Hair
- Baricitinib: A Review in Severe Alopecia Areata
- Updates From 2021 Virtual Dermatology Nurses' Association Convention
- Intrinsic Modulators of Hair Growth: Roles of Growth Factors, Cytokines, Chemokines, and Interferons
- Insights into the Diagnostics and Therapeutics of Alopecia Areata—An Indian Context
- P100: Efficacy of current treatments under study in patients with alopecia areata
- Innovative strategies for the discovery of new drugs against alopecia areata: taking aim at the immune system
- HX17 The fortunate side effect: serendipity and therapeutic innovation in dermatology
- When hair dig into the brain, JAKi , may help!
- Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series
- Could baricitinib treat frontal fibrosing alopecia and facial papules?
- Baricitinib as a treatment for myasthenia gravis: A case report
- A pilot study of 2% tofacitinib cream with narrowband ultraviolet B for the treatment of facial vitiligo
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- INVESTIGATING THE MECHANISMS UNDERLYING THE PATHOGENESIS OF ALOPECIA AREATA
- Upadacitinib for the Management of Alopecia Totalis and Subtotalis in Pediatric Patients: A Case Series
- USE OF UPADACITINIB IN 2 CASES OF REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS
- What is alopecia areata?
- CURRENT UNDERSTANDING OF VITILIGO: A COMPREHENSIVE LITERATURE REVIEW
- Deucravacitinib in dermatology: current indication and existing off-label data